Danish Electronic Equipment and Components Stock News

The Shape Robotics A/S ( CPH:SHAPE ) share price has fared very poorly over the last month, falling by a substantial...

RTX (CPSE:RTX) just released its full-year 2025 earnings, reporting fourth-quarter revenue of 146.7 million DKK and basic EPS of 0.55 DKK. Looking back, the company has seen revenue fluctuate, with figures ranging from 104.0 million DKK to 165.5 million DKK over the last four quarters, and basic EPS swinging from a loss of -0.90 DKK in Q1 to a high of 0.99 DKK in Q2. With EPS returning to positive territory and net income rising in recent quarters, investors are paying close attention to...

Key Insights Institutions' substantial holdings in H+H International implies that they have significant influence over...

With a price-to-earnings (or "P/E") ratio of 17.5x Demant A/S ( CPH:DEMANT ) may be sending bearish signals at the...

Vestas Wind Systems A/S ( CPH:VWS ) shares have had a really impressive month, gaining 25% after a shaky period...

Key Insights Ambu's Annual General Meeting to take place on 3rd of December Salary of kr.8.01m is part of CEO Britt...

Amid renewed concerns over inflated AI stock valuations and receding expectations for a U.S. interest rate cut, European markets have experienced a downturn, with major indexes such as the STOXX Europe 600 and Germany's DAX seeing notable declines. In this environment of cautious sentiment, identifying undervalued stocks can present opportunities for investors seeking value in solid fundamentals and potential for growth despite broader market challenges.

Nilfisk Holding A/S ( CPH:NLFSK ) just released its latest quarterly report and things are not looking great. It was a...

The cBrain A/S ( CPH:CBRAIN ) share price has fared very poorly over the last month, falling by a substantial 28%. The...

H. Lundbeck A/S ( CPH:HLUN B ) just reported healthy earnings but the stock price didn't move much. Our analysis...

Some FLSmidth & Co. A/S ( CPH:FLS ) shareholders may be a little concerned to see that the Group Chief Executive...

Danske Bank has commenced a substantial share buy-back programme of up to DKK 5 billion, executing purchases of 211,000 shares on Nasdaq Copenhagen in the past week, which represents 1.849% of its share capital to date. Share buy-back programmes of this scale can often reflect management’s confidence in the company’s fundamentals and contribute to improving earnings per share through reduced share count. We’ll explore how Danske Bank’s active share repurchases could influence its investment...

Despite TORM plc's ( CPH:TRMD A ) recent earnings report having lackluster headline numbers, the market responded...

Shareholders appeared unconcerned with Solar A/S' ( CPH:SOLAR B ) lackluster earnings report last week. We did some...

Zealand Pharma A/S ( CPH:ZEAL ) just released its latest third-quarter results and things are looking bullish. Revenue...

It's been a pretty great week for ALK-Abelló A/S ( CPH:ALK B ) shareholders, with its shares surging 15% to kr.230 in...

Last week, you might have seen that Matas A/S ( CPH:MATAS ) released its quarterly result to the market. The early...

Wondering if Ørsted's recent turbulence means the stock is a hidden bargain or a value trap? You're not alone, and the story behind the numbers is surprisingly layered. After years of struggles, Ørsted’s stock has rebounded 5.4% over the past week and 2.7% in the last 30 days, yet it is still down a striking 63.1% year-to-date and 43.3% over the past year. Recent headlines have centered around Ørsted’s abrupt project cancellations and the company’s ongoing efforts to stabilize its offshore...

Embla Medical has opened a new prosthetic clinic in Kyiv and, at the opening, announced a three-year partnership with the Government of Iceland to deliver prosthetic care and rehabilitation to up to 1,000 Ukrainian amputees, with a total program value of US$11 million co-financed by both parties and supported by Future for Ukraine. This initiative directly addresses Ukraine’s unprecedented need for advanced prosthetic support following the war, highlighting Embla Medical’s commitment to...

Zealand Pharma reported its third quarter 2025 results, announcing sales of DKK49.57 million and a quarterly net loss of DKK404.23 million, while nine-month sales reached DKK9.15 billion with net income of DKK6.83 billion. This rapidly shifting financial picture shows a swing from net loss to substantial net income over the nine-month period, underlining the impact of recent commercial developments. We'll now consider how Zealand's dramatic year-to-date earnings turnaround may influence the...

Vestas Wind Systems A/S ( CPH:VWS ) recently posted some strong earnings, and the market responded positively. Our...

GN Store Nord (CPSE:GN) just released its latest quarterly and nine-month earnings, offering investors a look at some challenging shifts. The company reported lower sales and a sharp drop in net income compared to last year, raising questions about its operational momentum. See our latest analysis for GN Store Nord. After the earnings announcement highlighted a slide in sales and net income, GN Store Nord’s share price has been grappling with renewed skepticism, even as the company steps up...

While ISS A/S ( CPH:ISS ) might not have the largest market cap around , it saw a double-digit share price rise of over...

As the European markets face pressures from concerns over artificial intelligence stock valuations, major indices like the STOXX Europe 600 and Germany's DAX have recently seen declines. In this environment, investors may find opportunities in value stocks that are trading at estimated discounts, offering potential resilience amidst market fluctuations.